As of 2026-03-08, the Relative Valuation of Iovance Biotherapeutics Inc (IOVA) is (29.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.13 USD, the upside of Iovance Biotherapeutics Inc based on Relative Valuation is -677.2%.
The range of the Relative Valuation is (28.84) - (28.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.6x - 25.5x | 25.0x |
| Forward P/E multiples | 20.4x - 22.5x | 21.4x |
| Fair Price | (28.84) - (28.69) | (29.61) |
| Upside | -662.2% - -659.2% | -677.2% |
| Date | P/E |
| 2026-03-06 | -4.03 |
| 2026-03-05 | -3.59 |
| 2026-03-04 | -3.34 |
| 2026-03-03 | -2.93 |
| 2026-03-02 | -2.97 |
| 2026-02-27 | -3.02 |
| 2026-02-26 | -2.97 |
| 2026-02-25 | -3.00 |
| 2026-02-24 | -2.96 |
| 2026-02-23 | -2.26 |
| 2026-02-20 | -2.25 |
| 2026-02-19 | -2.23 |
| 2026-02-18 | -2.13 |
| 2026-02-17 | -2.05 |
| 2026-02-13 | -2.01 |
| 2026-02-12 | -1.97 |
| 2026-02-11 | -2.04 |
| 2026-02-10 | -2.04 |
| 2026-02-09 | -2.04 |
| 2026-02-06 | -1.98 |
| 2026-02-05 | -1.85 |
| 2026-02-04 | -1.91 |
| 2026-02-03 | -2.07 |
| 2026-02-02 | -2.05 |
| 2026-01-30 | -2.00 |
| 2026-01-29 | -2.06 |
| 2026-01-28 | -2.15 |
| 2026-01-27 | -2.34 |
| 2026-01-26 | -2.26 |
| 2026-01-23 | -2.07 |
| 2026-01-22 | -2.11 |
| 2026-01-21 | -1.97 |
| 2026-01-20 | -1.91 |
| 2026-01-16 | -1.85 |
| 2026-01-15 | -1.74 |
| 2026-01-14 | -1.86 |
| 2026-01-13 | -1.84 |
| 2026-01-12 | -1.88 |
| 2026-01-09 | -1.92 |
| 2026-01-08 | -2.05 |
| 2026-01-07 | -2.17 |
| 2026-01-06 | -2.00 |
| 2026-01-05 | -1.92 |
| 2026-01-02 | -1.97 |
| 2025-12-31 | -2.14 |
| 2025-12-30 | -2.17 |
| 2025-12-29 | -2.19 |
| 2025-12-26 | -2.23 |
| 2025-12-24 | -2.25 |
| 2025-12-23 | -2.21 |